A B S T R A C T The possible suppressive effects of 24,25-dihydroxycholecalciferol on secondary hyperparathyroidism and increased bone resorption were investigated in adult rats raised on a diet normal in calcium, phosphorus, and vitamin D, and subjected to acute bilateral nephrectomy. The animals had received subcutaneous radiocalcium 4 wk before the experiment. 5 h after nephrectomy an increase in serum total calcium, 45Ca-specific activity, citrate, phosphorus, and magnesium concentrations were observed. Serum immunoreactive parathyroid hormone increased, while serum calcitonin decreased. The osteoclast count in the tibial metaphyses was augmented. The biochemical and histological changes observed were partly parathyroid hormone and calcitonin independent, as they also occurred in parathyroidectomized hypocalcemic rats. Pretreatment with 650 pmol of 24,25-dihydroxycholecalciferol 16 h before nephrectomy prevented bone calcium mobilization and diminished the rise in serum total calcium and citrate both in parathyroidintact and in parathyroidectomized animals. In parathyroid-intact rats, serum immunoreactive parathyroid hormone and calcitonin remained normal in spite of the fall in serum-ionized calcium, and the number of osteoclasts did not increase. In parathyroidectomized rats, 24,25-dihydroxycholecalciferol did not prevent the postnephrectomy rise in the osteoclast count. This latter observation suggests that this metabolite exerts its effect on bone either by acting on cells other than osteoclasts, i.e., the osteocytes, or by inhibiting cell activity. At equimolar dosage 1,25-dihydroxycholecalciferol had a potent stimulatory effect on bone resorption. This effect of 1,25-dihydroxycholecalciferol was partly blocked by the simultaneous administration of 24,25-dihydroxycholecalciferol. The potential clinical significance of these observations remains to be determined.
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INTRODUCTION
It is well established that vitamin D3 (cholecalciferol) must undergo metabolic conversion in order to promise its physiological actions (1) (2) (3) (4) . The first conversion occurs in the liver and leads to the formation of 25- hydroxycholecalciferol. This metabolite is the major circulating form of vitamin D3, and is the precursor of dihydroxylated derivatives: 1,25-dihydroxycholecalciferol (1, , ' 24,25- (1, 5, 6) . Recent (11) (12) (13) . In vitro studies from our laboratory produced evidence that 24,25-(OH)2D3 at very low concentrations stimulates the synthesis of specific proteoglycans by chondrocytes (14) and suppresses the action of agents known to stimulate bone resorption, such as parathyroid hormone, vitamin D, and heparin (15, 16) . A few clinical trials have led to the assumption that 24,25-(OH)2D3 may be the metabolite that principally promotes bone formation (17) . At the present time, no information is available on a possible in vivo suppressive effect of this metabolite on bone resorption.
We have investigated this point in view of the potential therapeutic value of 24,25-(OH)2D3 in the management of the pathological increases in bone resorption. Bilaterally nephrectomized rats were chosen as experimental models, as this procedure provokes a marked increase in bone calcium mobilization. Our results demonstrate that a single pharmacological dose of 24,25-(OH)2D3, i.e., 650 pmol, has a potent inhibitory effect on the biochemical and histological changes of increased bone resorption observed 5 h after nephrectomy, and partly blocks the stimulatory effect of 1,25-(OH)2D3 on bone resorption. These effects appear to be related not only to an inhibitory action on parathyroid gland hypersecretion, but also to the depression of bone-cell response to parathyroid hormone, 1,25-(OH)2D3, and acute uremia.
METHODS
Male Wistar rats weighing 180-200 g were fed a diet containing 0.45% calcium, 0.30% phosphorus, and 30 IU/g of vitamin D3 (Laboratoire Roussel, Paris, France). The animals were randomly separated into two main groups: those to undergo a bilateral nephrectomy, and those to undergo a sham operation. In each major group a subgroup of animals was injected intraperitoneally with 650 pmol of 24,25-(OH)2D3 or 1,25-(OH)2D3, or with a combination of650 pmol of 24,25- (19) . The SpaceStat 2 ionized calcium analyzer (Orion-Biomedical Division, Orion Research, Cambridge, England) was used for serumionized calcium determinations. Blood pH was measured at 37°C with a capillary glass pH-electrode (Ingold, Zurich, Switzerland). Parathyroid hormone levels were estimated radioimmunologically with [1311]iodo-bovine PTH-(bPTH [-84] ) and anti-bPTH serum (chicken 12 M), as previously described (20) . The coefficient of variation of the assay is 12%. Calcitonin levels were measured by radioimmunoassay according to the technique of Heynen and Franchimont (21) modified according to the method of Roos and Deftos (22) . For concentrations of iCT varying from 100 to 1,000 pg/ml the interassay variation is 5%. Determinations of 45Ca were performed by spotting 0.5 ml of serum in Instagel solution. The radioactivity was counted with a Packard-Tri-Carb liquid scintillation spectrometer (model 3320, Packard Instrument Co., Downers Grove, Ill.), equipped with an external standardization system.
For osteoclast counts, both proximal tibial metaphyses were fixed in a mixture of 2% glutaraldehyde (Ladd Research Industries, Inc., Burlington, Vt.) and 1.2% formaldehyde (Merck, AG, Darmstadt, West Germany), decalcified in 10% ethylene-diamine-tetracetic acid (Prolabo, Paris, France), and embedded in esterwax (BDH Chemicals Ltd., Poole, England). 4-Am-thick transverse sections were stained with toluidine blue (BDH Chemicals Ltd.,) at pH 6.4. Osteoclasts were identified as large multinucleated cells with foamy cytoplasm on or near bone surfaces. Osteoclasts with a single nucleus were identified by their cytoplasmic appearance and their typical brush border. All osteoclasts were counted at the ossification zone 2,000 ,um below the cartilage plate at magnification x500 over an area of 2.18 mm2. The value for each animal represents the means of the cell numbers in three sections in the middle of the metaphyses at 200 ,um distance from each other. The fact that the selected area could be considered representative of the whole metaphyseal zone was previously ascertained by counting in two animals the osteoclast numbers on sections taken at 200-,um distance over the whole metaphysis.
Results were expressed as mean values±SEM. The significance of the differences between groups was assessed by Student's t test (23) .
RESULTS
Effects of nephrectomy in parathyroid-intact and parathyroidectomized animals. Compared with shamoperated animals, nephrectomized parathyroid-intact rats had significantly higher serum total calcium, citrate, phosphorus, and magnesium concentrations (Table I) . Serum 45Ca-specific activity was increased, and ionized calcium concentration significantly decreased 5 h after nephrectomy without any significant change in blood pH or serum total protein concentration. Serum iPTH levels reached 10.5+2.5 vs. 2.0+0.54 ,uleq/ml in sham-operated controls, and serum iCT was decreased to less than half the control value. In tibial metaphyses a highly significant (P < 0.001) augmentation in osteoclast number was found in nephrectomized rats.
In previously parathyroidectomized animals (Table  I ) nephrectomy was also followed by an increase in serum total calcium, 45Ca-specific activity, phosphorus, and magnesium. However, the increase in The intraperitoneal administration of 650 pmol of 24,25-(OH)2D3 16 h before nephrectomy significantly reduced the hypercalcemic and hypercitratemic responses to nephrectomy both in parathyroid-intact (Table II) and in parathyroidectomized rats (Table III) . These suppressive effects were accompanied by an in- (Table II) 
DISCUSSION
The results of the present investigation indicate two conclusions. The first concerns some biological anomalies manifest 5 h after bilateral nephrectomy in rats, i.e., the increase in bone resorption and the marked rise in serum calcium concentration. The second conclusion concerns the comparative effects of24,25-(OH)2D3 and 1,25-(OH)2D3 in this model of acute renal failure.
The hypercalcemia that characterizes the early period following bilateral nephrectomy is a well-known phenomenon in experimental animals (25) (26) (27) (28) (29) . It has also been occasionally reported in man suffering from acute renal failure (30) (31) (32) (33) (34) .
On the basis of indirect data such as sequential analysis of serum citrate variations (26, 29) and the study of the calcium fraction chelated by circulating phosphate (28) , it has been suggested that this early hypercalcemia is accompanied by a decrease in serumionized calcium concentration, the latter stimulating parathyroid hormone secretion. The measurement of serum ionized calcium and iPTH concentrations performed in the present study support these assumptions. Furthermore, our results show for the first time to our knowledge that in this experimental model circulating concentrations of iCT are lowered after acute nephrectomy. This decrease is not due to a dilutional effect of nephrectomy, since total protein in serum is not changed. Apparently, the increased bone resorption, as evaluated by the rise in serum total calcium and specific activity of 45Ca, is mediated by a stimulation of parathyroid hormone secretion and additionally caused by a fall in the serum concentration of calcitonin. The kidney is important for the clearance of both active and inactive fragments of these hormones (35, 36 is observed even though equimolar doses of the two metabolites are used. Yet, since the circulating concentrations of 1,25-(OH)2D3 are -0.1 of those of 24,-25-(OH)2D3, the amount of 1,25-(OH)2D3 given to our animals is clearly much higher than the 24,25-(OH)2D3 they received. This difference, however, is compensated by the fact that the half-life of 1,25-(OH)2D3 is shorter when compared with that of 24,25-(OH)2D3, and short compared with the 16-h period between the administration of this metabolite and nephrectomy (1) .
It should be noted that pretreatment with 24,25-(OH)2D3 prevents the increase in the number of osteoclasts in tibial metaphyses in parathyroid-intact rats. Even though a comparable inhibition of the release of previously incorporated 45Ca is also seen in parathyroidectomized rats pretreated with 24,25-(OH)2D3, a reduction of the number of osteoclasts was not observed. This observation suggests either that the inhibitory effect of 24,25-(OH)2D3 on bone resorption involves cells other than osteoclasts, i.e., osteocytes, and/or that this metabolite suppresses the activity of the osteoclasts and not their numbers.
In conclusion, our study demonstrates the high po- 
